Annals of Indian Academy of Neurology
  Users Online: 264 Home | About the Journal | InstructionsCurrent Issue | Back IssuesLogin      Print this page Email this page  Small font size Default font size Increase font size
ORIGINAL ARTICLE
Year : 2010  |  Volume : 13  |  Issue : 4  |  Page : 257-262

Role of vitamin B 12 , folate, and thyroid stimulating hormone in dementia: A hospital-based study in north Indian population


1 Department of Neurochemistry, Institute of Human Behaviour & Allied Sciences, Delhi, India
2 Department of Neurology, Institute of Human Behaviour & Allied Sciences, Delhi, India
3 Department of Biostatics, Institute of Human Behaviour & Allied Sciences, Delhi, India

Correspondence Address:
Rachna Agarwal
Department of Neurochemistry, Institute of Human Behaviour & Allied Sciences, Dilshad Garden, Delhi - 110 095
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0972-2327.74193

Rights and Permissions

Background: Vitamin B 12 and folate represent modifiable risk factors for dementia. They may increase the risk of Alzheimer's dementia (AD) and vascular dementia (VaD) as their deficiency can increase the homocysteine level due to slowed methylation reaction. Homocysteine has a neurotoxic effect that could lead to neurologic disturbances. Hence, it is important to explore the status of serum B 12 and folate in AD and VaD to evolve the treatment strategies for the same. Objectives: A retrospective study was conducted to assess the levels of vitamin B 12 , folate, and thyroid stimulating hormone (TSH) in serum and the relationship of these factors, including age and sex to cognitive decline in VaD, AD, and dementia due to other causes (DOC). Materials and Methods: Serum vitamin B 12 , folate, TSH, and total cholesterol were studied in 32 AD patients (mean age: 65 years), 12 VaD patients (mean age: 61 years), 83 DOC (mean age: 65 years), and 127 control subjects (mean age: 49 years). Results: In AD, VaD, and DOC, the levels of vitamin B 12 and folate were significantly lower (P < 0.002; 0.026; 0.002 for vitamin B 12 and P < 0.000 in all the 3 groups for folate) as compared with the controls. Similarly, TSH levels were significantly lower in AD and DOC (P < 0.008; 0.038) as compared with the controls. Conclusion: Vitamin B 12 and folate were significantly low in both AD and VaD patients. Hence, B vitamin supplementation should be considered as possible targets for the therapeutic intervention in dementia.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed4078    
    Printed191    
    Emailed2    
    PDF Downloaded110    
    Comments [Add]    
    Cited by others 2    

Recommend this journal